Low testosterone in men produces a recognizable cluster of symptoms across physical, sexual, and psychological domains. The 15 signs listed here are derived from clinical diagnostic criteria used by the Endocrine Society and reflect the most consistently reported symptoms in hypogonadism research. No single symptom confirms low testosterone. The diagnosis requires laboratory confirmation on at least two morning blood draws. But if you recognize multiple symptoms from this list, a testosterone evaluation is clinically warranted.
Why Low Testosterone Is Frequently Missed
The symptoms of low testosterone are non-specific. Fatigue, low mood, and reduced libido are common complaints in primary care settings that are attributed to stress, poor sleep, aging, or depression before a hormonal cause is considered. The Endocrine Society’s clinical practice guidelines identify this diagnostic delay as a systemic problem: many men live with treatable hypogonadism for years because the hormonal component was never tested.
Compounding this, testosterone levels follow a circadian rhythm and decline progressively with age, making a single afternoon blood draw unreliable. Normal reference ranges are population-derived and include a wide age span, meaning a 45-year-old man at the bottom of the “normal” range may be functioning at the 5th percentile for his age cohort. Symptoms provide the clinical context that lab values alone cannot.
The symptoms listed below are consistent with hypogonadism but also overlap with thyroid dysfunction, depression, sleep apnea, anemia, and other conditions. A diagnosis of hypogonadism requires total testosterone below 300 ng/dL on two separate morning draws (8 to 10 AM), combined with clinical symptoms. Treating low testosterone in men without laboratory confirmation is not appropriate clinical practice.
The 15 Signs of Low Testosterone
Physical symptoms
1. Persistent fatigue and low energy. The most universally reported symptom. Men with low testosterone describe fatigue that is qualitatively different from ordinary tiredness: it is present on waking, does not resolve with rest, and interferes with daily function. The mechanism involves testosterone’s role in red blood cell production (erythropoiesis) and mitochondrial energy metabolism. Low testosterone reduces hemoglobin and impairs cellular energy production independently of sleep quality.
2. Reduced muscle mass and strength. Testosterone is the primary anabolic hormone in men. It stimulates protein synthesis, inhibits protein breakdown, and regulates satellite cell activity responsible for muscle repair. As testosterone falls, men lose lean mass even without changes in diet or exercise. The decline is often gradual — perceived initially as reduced strength or slower recovery rather than visible muscle wasting.
3. Increased body fat, particularly visceral. Low testosterone is directly associated with increased adiposity, particularly in the visceral (abdominal) compartment. This is partly driven by reduced lipolysis and partly by increased aromatase activity in adipose tissue, which converts remaining testosterone to estradiol, further lowering effective testosterone levels. The resulting metabolic shift is bidirectional: obesity lowers testosterone, and low testosterone promotes obesity.
4. Reduced bone density. Testosterone maintains bone mineral density throughout adulthood. Hypogonadal men have measurably lower bone density than eugonadal men of comparable age and are at elevated fracture risk, particularly at the spine and hip. Bone loss from hypogonadism is typically asymptomatic until a fracture occurs, making it one of the most clinically underappreciated consequences of untreated low testosterone.
5. Hot flushes and sweating. Vasomotor symptoms in men are less discussed than in women but are documented in hypogonadism literature. Abrupt testosterone decline, such as after stopping testosterone therapy or following bilateral orchiectomy, produces hot flushes comparable in mechanism to those of female menopause. In gradual-onset hypogonadism, vasomotor symptoms are milder but may present as unexplained night sweats or temperature sensitivity.
6. Hair loss (body and facial hair). Testosterone drives androgenic hair growth on the face, chest, axillae, and pubic region. Men with low testosterone may notice reduced beard growth rate, thinning body hair, and less frequent shaving requirements. Scalp hair loss (androgenetic alopecia) is driven by DHT, a testosterone metabolite, and paradoxically may be reduced in hypogonadal men. Body and facial hair loss is the more reliable indicator of testosterone deficiency.
Sexual symptoms
7. Reduced libido. Sexual desire is the most testosterone-dependent psychological function in men. It is consistently the first symptom to appear as testosterone declines and is reported by the majority of hypogonadal men. Reduced libido is distinct from erectile dysfunction: a man can maintain erections but have little interest in sex. The absence of spontaneous sexual thought or fantasy is a clinically meaningful indicator of testosterone deficiency.
8. Erectile dysfunction. Testosterone does not directly cause erections, but it maintains the penile vascular and neural infrastructure required for erectile function. Hypogonadal men experience reduced frequency of morning and spontaneous erections, impaired erectile quality, and longer refractory periods. Erectile dysfunction has multiple causes, and testosterone deficiency is one that is specifically and reversibly treatable. All men presenting with ED should have testosterone measured.
9. Reduced ejaculatory volume and fertility impairment. Testosterone supports spermatogenesis through FSH and LH signaling. Low testosterone is associated with reduced sperm count, reduced seminal vesicle output (lower ejaculatory volume), and male factor infertility. Men with low testosterone who are attempting to conceive require fertility-preserving hormonal approaches, as standard testosterone replacement therapy suppresses spermatogenesis. See our guide on the connection between low testosterone and mood for related context on hormonal health.
10. Testicular atrophy. The testes produce approximately 95% of circulating testosterone. When LH signaling is reduced (secondary hypogonadism) or testicular function fails (primary hypogonadism), testicular volume decreases. Men may notice smaller, softer testicles over time. Testicular atrophy is a strong physical indicator of hypogonadism and warrants prompt laboratory evaluation.
Psychological and cognitive symptoms
11. Depressed mood and anhedonia. Testosterone modulates serotonin synthesis, dopaminergic tone, and neuroinflammatory markers in mood-regulating brain regions. Low testosterone produces depressive symptoms that are clinically indistinguishable from primary major depressive disorder. Men with treatment-resistant depression have a significantly higher prevalence of hypogonadism than antidepressant responders. Testosterone evaluation is warranted in any man whose depression does not respond to standard treatment.
12. Irritability and mood instability. Emotional volatility, low frustration tolerance, and increased irritability are consistently reported in hypogonadal men. These symptoms often predate the recognition of other hypogonadism signs and may be attributed to stress or personality factors. The mechanism involves testosterone’s regulation of amygdala reactivity and cortisol response modulation.
13. Poor concentration and cognitive fog. Testosterone receptors are expressed in the hippocampus and prefrontal cortex, regions central to working memory, attention, and executive function. Hypogonadal men report difficulty concentrating, reduced cognitive sharpness, and mental sluggishness often described as “brain fog.” These symptoms respond to testosterone normalization, particularly in men whose deficiency is confirmed and whose other cognitive health factors (sleep, thyroid function) are addressed.
14. Reduced motivation and drive. The mesolimbic dopamine pathway, which governs motivation and goal-directed behavior, is androgen-dependent. Men with low testosterone frequently describe a loss of ambition, reduced initiative, and difficulty sustaining effort toward goals. This is distinct from depression, though the two often co-occur. Reduced drive is one of the symptoms most consistently reported to improve after TRT in hypogonadal men.
15. Poor sleep quality. Low testosterone and sleep disruption are bidirectionally linked. Seventy percent of daily testosterone production occurs during sleep, primarily during slow-wave stages. Sleep deprivation and sleep apnea both suppress testosterone production. Conversely, low testosterone is independently associated with lighter sleep architecture, more frequent awakenings, and reduced slow-wave sleep. Men with both low testosterone and suspected sleep apnea should address both concurrently.
15 Signs of Low Testosterone: Symptom Domains at a Glance
Symptoms are consistent with hypogonadism but require laboratory confirmation. Multiple symptoms across domains increase clinical probability.
How Many Symptoms Do You Need for a Diagnosis?
There is no minimum symptom count that confirms low testosterone. The Endocrine Society guidelines state that testosterone therapy should only be initiated in men with both confirmed biochemical hypogonadism (total testosterone below 300 ng/dL on two morning draws) and symptoms consistent with deficiency. However, clinical probability increases meaningfully when multiple symptoms are present across more than one domain.
The ADAM questionnaire (Androgen Deficiency in Aging Males) is a validated 10-question screening tool commonly used in primary care. A positive screen (answering yes to questions 1 or 7, or any 3 other questions) identifies men who should proceed to laboratory testing. The questionnaire is not diagnostic but serves as a structured entry point for clinical evaluation.
Low Testosterone vs. Normal Aging: How to Tell the Difference
Testosterone does decline with age — but the rate and magnitude vary significantly between men, and symptomatic hypogonadism is not an inevitable consequence of aging. Understanding what is expected vs. what warrants evaluation helps men and clinicians avoid two opposite errors: over-attributing normal aging symptoms to testosterone deficiency, and dismissing genuine hypogonadism as “just getting older.”
| Symptom | Normal Aging | Likely Hypogonadism |
|---|---|---|
| Energy | Gradual mild decline; better on rest days | Persistent regardless of sleep; present on waking |
| Libido | Gradual moderation; responsive to context | Absent or very low regardless of context; no spontaneous thoughts |
| Muscle mass | Slow loss over decades; maintained with training | Accelerated loss despite training; reduced strength disproportionate to age |
| Mood | Stable with normal life stressors | Persistent low mood, anhedonia, or irritability without clear cause |
| Body fat | Gradual increase manageable with diet | Rapid visceral gain despite diet unchanged; loss of muscle with fat gain simultaneously |
| Morning erections | Less frequent but still present | Absent or very infrequent for extended periods |
Conditions That Mimic Low Testosterone Symptoms
Because the symptoms of hypogonadism overlap extensively with other common conditions, a complete diagnostic workup rules out these alternatives before attributing symptoms to testosterone deficiency alone.
- Hypothyroidism: Fatigue, weight gain, low mood, reduced libido, and cognitive slowing are shared symptoms. TSH should always be checked alongside testosterone in the initial workup.
- Obstructive sleep apnea: Directly suppresses testosterone through sleep fragmentation and intermittent hypoxia. Men with untreated sleep apnea consistently show lower testosterone. Treating sleep apnea can raise testosterone without hormonal intervention.
- Type 2 diabetes and insulin resistance: Strong bidirectional relationship with testosterone deficiency. Both conditions worsen the other. Blood glucose, HbA1c, and metabolic panel are standard components of the hypogonadism workup.
- Major depressive disorder: Produces many of the same psychological symptoms as hypogonadism. Elevated cortisol in depression independently suppresses testosterone via HPA-HPG axis crosstalk.
- Anemia: Iron-deficiency and other anemias produce fatigue and reduced exercise tolerance overlapping with hypogonadism. CBC should be included in the initial panel.
- Hyperprolactinemia: Elevated prolactin suppresses GnRH and causes secondary hypogonadism. Prolactinoma must be ruled out in men with low LH and low testosterone, particularly with galactorrhea or visual field changes.
What Labs to Request and How to Get Tested
If you recognize multiple symptoms from the list above, the next step is a targeted laboratory evaluation. Do not rely on a single testosterone value drawn at any time of day. The following panel provides the information needed to confirm hypogonadism and determine its type.
Recommended Lab Panel for Suspected Low Testosterone
Over-the-counter testosterone boosters are not regulated and have no clinical evidence supporting meaningful testosterone elevation. Anabolic steroids obtained without prescription are illegal and suppress the HPG axis, worsening hypogonadism long-term. Self-administering testosterone without a confirmed diagnosis and physician oversight can cause polycythemia, cardiovascular complications, and permanent suppression of natural testosterone production. If you suspect low testosterone, the appropriate first step is a laboratory evaluation with a qualified clinician.
What Happens After Diagnosis: Treatment Options
Confirmed hypogonadism has established, effective treatments. The choice of treatment depends on whether fertility preservation is a priority, the severity of symptoms, the likely cause of deficiency, and patient preference for delivery method.
Testosterone replacement therapy (TRT) is the primary treatment for hypogonadism in men not seeking fertility. It is available as weekly or biweekly intramuscular or subcutaneous injections, daily transdermal gels or creams, or subcutaneous pellets inserted every 3 to 6 months. All deliver testosterone to therapeutic levels; the formulations differ in stability, convenience, and practical considerations. TRT suppresses endogenous testosterone production and spermatogenesis, which is why fertility-seeking men require different protocols.
Clomiphene citrate is an off-label option for men with secondary hypogonadism who wish to preserve fertility. By blocking estrogen receptors at the hypothalamus, it increases GnRH pulsatility and drives LH and FSH secretion, stimulating endogenous testosterone production without suppressing sperm production.
hCG (human chorionic gonadotropin) mimics LH at the testicular level, directly stimulating testosterone production. It is used alone or in combination with clomiphene, particularly in men with primary testicular insufficiency or those transitioning off TRT who wish to restore endogenous production.
For a full clinical overview of low testosterone, its connection to mental health, and how hormonal evaluation integrates with psychiatric assessment, see our article on depression and low testosterone: the hidden connection.
In men with secondary hypogonadism driven by modifiable factors, addressing lifestyle before initiating TRT is appropriate. Resistance training increases testosterone by 15 to 25% acutely and supports long-term HPG axis function. Reducing body fat (particularly visceral fat) decreases aromatase activity and raises effective testosterone. Treating obstructive sleep apnea can raise testosterone by 10 to 15% through restoring slow-wave sleep. Reducing alcohol intake and chronic stress removes two of the most modifiable suppressors of LH secretion. These changes do not replace TRT in confirmed primary hypogonadism but can meaningfully improve symptoms and testosterone levels in borderline or secondary presentations.
Get Evaluated: Start With a Clinical Consultation
If you recognize multiple symptoms from this list, the appropriate next step is a comprehensive hormonal and metabolic evaluation, not self-treatment. Advanced TRT Clinic provides physician-supervised testosterone evaluation and treatment via telemedicine, including lab coordination, clinical interpretation, and ongoing management. Availability varies by state.
